Left ventricular hypertrophy | |||||
Parameters | Yes (n = 21) | No (n = 14) | p-value | OR | CI (95%) |
Gender | |||||
Male | 19 (64.6%) | 7 (50%) | 0.019 | 3.51 | 1.20 - 10.27 |
Female | 2 (9.5%) | 7 (50%) | 0.33 | 0.43 | 0.08 - 2.42 |
Age range | |||||
<55 years | 15 (71.4%) | 6 (42.9%) | 0.02 | 3.47 | 1.13 - 10.68 |
≥55 years | 6 (28.6%) | 8 (57.1%) | 0.97 | 1.02 | 0.27 - 3.80 |
Medical history | |||||
HBP | 17 (80.9%) | 13 (92.8%) | 0.18 | 1.87 | 0.75 - 4.65 |
Diabetes | 2 (9.5%) | 5 (35.7%) | 1.22 | 0.22 | 0.03 - 1.59 |
Initial nephropathy | |||||
CGN | 8 (38.1%) | 9 (64.3%) | 0.96 | 1.03 | 0.33 - 3.20 |
Hypertensive nephropathy | 13 (61.9%) | 3 (21.4%) | 0.01 | 1.18 | 0.45 - 3.12 |
CTIN | 0 | 2 (14.3%) | - | - | - |
CKD stage | |||||
GFR < 15 ml/min | 18 (85.7%) | 12 (85.7%) | 0.15 | 1.92 | 0.78 - 4.71 |
GFR ≥ 15 ml/min | 3 (14.3%) | 2 (14.3%) | 0.31 | 3.00 | 0.35 - 25.87 |
Clinical signs | |||||
RHS | 4 (19.05%) | 7 (50%) | 0.01 | 3.45 | 1.20 - 9.94 |
TAS ≥ 160 mmHg | 8 (38.1%) | 11 (78.6%) | 0.30 | 1.77 | 0.60 - 5.25 |
TAD ≥ 100 mmHg | 9 (42.9%) | 7 (50%) | 0.24 | 2.14 | 0.59 - 7.77 |
Biological signs | |||||
Hb level < 8 g/dl | 15 (71.4%) | 7 (50%) | 0.05 | 2.86 | 0.96 - 8.46 |
Hypocalcemia | 14 (66.7%) | 13 (92.8%) | 0.92 | 0.99 | 0.39 - 2.53 |
Hyperphosphatemia | 11 (52.4%) | 7 (50%) | 0.39 | 1.68 | 0.51 - 5.56 |
CRP ≥ 20 mg/l | 19 (90.5%) | 12 (85.7%) | 0.03 | 2.71 | 1.1 - 6.68 |